MAAT INDEX

CLAIM #43523 · Merck & Company Inc (MRK) · 2025Q1 earnings call · Apr 24, 2025 · due Dec 31, 2028

I expect, frankly, that number is gonna grow. Going forward.

Rob Davis · CEO

PENDING
graded after results covering Dec 31, 2028 are reported

How to check this claim

Look at: Cumulative disclosed capital investment in supply chain/manufacturing rebalancing (US for US, Europe for Europe, Asia for Asia initiative), as stated by management

It came true if: Cumulative disclosed spending figure exceeds $21 billion (the $12B already spent plus $9+B additional announced as of this statement)

Where: Management commentary on earnings calls / investor presentations disclosing cumulative supply chain investment figures

In context

tes to the existing tariffs that have been announced largely between China and the US and to a lesser extent, Canada and Mexico. I think you're really referring to the potential for further sector-specific tariffs that could come and what we're doing. And in that regard, you know, we've been very focused, and I tried to highlight this in the script. We've actually had started to change and rebalance our supply chain strategy going back actually beginning with the Tax Cut and Jobs Act. Where we started moving more towards being able to have US for US Europe for Europe, and Asia for Asia. And we've been in the process of doing that. That was a big part of where we announced that we've spent $12 billion since that time to date. And then we expect to spend an additional 9 plus billion dollars I expect, frankly, that number is gonna grow. Going forward. So we have already been in the process of changing our supply chain. But what we've done is specifically in the near term, we have, I think, done a good job of managing our M. So as you look at 2025, we're well-positioned with inventory to be able to mitigate anything we could see in the short term. And then in the medium to long term, we've already started to identify where we can either reposition our own manufacturing, so, change the priorities of existing plants, bring on external manufacturing, in some cases, to bridge gaps. And then finally, to build internal manufacturing long term. So that we have that in our base going forward. So, really, as I look at it, short term, I think we're in a good shape. Medium and long term, we're taking the steps to position ourselves. And that reall

Verify independently

SEC filings for MRK · Claim quote is verbatim from the 2025Q1 earnings call.